The Long Run with Luke Timmerman
Een podcast door Timmerman Report
173 Afleveringen
-
Ep175: Andy Scharenberg on in vivo CAR-T cell therapies
Gepubliceerd: 16-3-2025 -
Ep174: Najat Khan on the TechBio Movement
Gepubliceerd: 3-3-2025 -
Ep173: Robert Blum on Building a Fully Integrated Biopharma For Muscle Disorders
Gepubliceerd: 11-2-2025 -
Ep172: Mostafa Ronaghi on Studying Live Cells at Scale
Gepubliceerd: 27-1-2025 -
Ep171: Ram Aiyar on RNA Editing Medicines
Gepubliceerd: 13-1-2025 -
Ep170: David Schenkein on Investing in the Future of Biotech
Gepubliceerd: 2-1-2025 -
Ep169: Kevin Fitzgerald on the Past & Future of RNAi Medicines
Gepubliceerd: 11-12-2024 -
Ep168: Jonathan Bricker on How to Quit Smoking & Prevent Cancer
Gepubliceerd: 25-11-2024 -
Ep167: Leslie Williams on transfer RNA therapies
Gepubliceerd: 6-11-2024 -
Ep166: Chris Garcia on Engineering Protein Drugs for Cancer, Autoimmunity
Gepubliceerd: 15-10-2024 -
Ep165: Zach Hornby on Tackling Cancer Drug Resistance
Gepubliceerd: 26-9-2024 -
Ep164: Ted Love and Alan Anderson on Raising the Bar for Sickle Cell Disease Patients
Gepubliceerd: 5-9-2024 -
Ep163: Sarah Boyce on RNA Medicines for Muscle Diseases
Gepubliceerd: 14-8-2024 -
Ep162: Sean McClain on AI for Biologic Drug Discovery
Gepubliceerd: 16-7-2024 -
Ep161: Jeff Stein on a Long-Lasting Flu Drug
Gepubliceerd: 1-7-2024 -
Ep160: Abe Ceesay on Precision Neuroscience
Gepubliceerd: 17-6-2024 -
Ep159: Jimi Olaghere on Being Functionally Cured of Sickle Cell Disease
Gepubliceerd: 3-6-2024 -
Ep158: David Younger and Randolph Lopez on SynBio & AI for Discovery
Gepubliceerd: 20-5-2024 -
Ep157: Vineeta Agarwala of A16Z on Investing in AI for Drug Discovery
Gepubliceerd: 1-5-2024 -
Ep156: David Liu on New Tools and Techniques for Biology
Gepubliceerd: 16-4-2024
"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
